Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Vivas, Yurena ^a   Martínez García, Cristina ^a   Izquierdo, Adriana ^a   Garcia Garcia, Francisco ^b   Callejas, Sergio ^c   Velasco, Ismael ^a   Campbell, Mark ^d   Ros, Manuel ^a   Dopazo, Ana ^c   Dopazo, Joaquin ^b   Vidal Puig, Antonio ^d   Medina Gomez, Gema ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADAPTATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL EXPANSION; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PANCREAS ISLET BETA CELL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; PRIORITY JOURNAL; TRANSCRIPTOMICS; ANIMAL; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; OBESITY; OXIDATION-REDUCTION; PHOSPHORYLATION; PPAR GAMMA; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84855164474     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-86     Document Type: Article

References (40)

1. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR, Lancet 1992 340 8825 925 929 10.1016/0140-6736(92)92814-V 1357346
2. Islet beta cell failure in type 2 diabetes. Prentki M, Nolan CJ, J Clin Invest 2006 116 7 1802 1812 10.1172/JCI29103 16823478 (Pubitemid 44033300)
3. Expansion of beta-cell mass in response to pregnancy. Rieck S, Kaestner KH, Trends Endocrinol Metab 2010 21 3 151 158 10.1016/j.tem.2009.11.001 20015659
4. Genome-wide associations and metabolic disease: the big revolution. Doria A, Abumrad NA, Curr Opin Clin Nutr Metab Care 2008 11 4 363 365 10.1097/MCO.0b013e32830460d7 18541992
5. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, et al. Science 2007 316 5829 1331 1336 17463246 (Pubitemid 46871653)
6. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, et al. Science 2007 316 5829 1341 1345 10.1126/science.1142382 17463248 (Pubitemid 46871655)
7. A genome-wide association study identifies novel risk loci for type 2 diabetes. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, et al. Nature 2007 445 7130 881 885 10.1038/nature05616 17293876
8. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, et al. Nat Genet 2007 39 6 770 775 10.1038/ng2043 17460697 (Pubitemid 46848592)
9. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, et al. Science 2007 316 5829 1336 1341 10.1126/science.1142364 17463249 (Pubitemid 46871654)
10. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Spiegelman BM, Diabetes 1998 47 4 507 514 10.2337/diabetes.47.4.507 9568680 (Pubitemid 28160438)
11. Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Rosen ED, Kulkarni RN, Sarraf P, Ozcan U, Okada T, Hsu CH, Eisenman D, Magnuson MA, Gonzalez FJ, Kahn CR, et al. Mol Cell Biol 2003 23 20 7222 7229 10.1128/MCB.23.20.7222-7229.2003 14517292 (Pubitemid 37214026)
12. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR, Cell 1997 88 4 561 572 10.1016/S0092-8674(00)81896-6 9038347 (Pubitemid 27154421)
13. Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation. Hull RL, Kodama K, Utzschneider KM, Carr DB, Prigeon RL, Kahn SE, Diabetologia 2005 48 7 1350 1358 10.1007/s00125-005-1772-9 15937671 (Pubitemid 41186101)
14. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Parsons JA, Brelje TC, Sorenson RL, Endocrinology 1992 130 3 1459 1466 10.1210/en.130.3.1459 1537300
15. Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. Sachdeva MM, Stoffers DA, Mol Endocrinol 2009 23 6 747 758 10.1210/me.2008-0400 19196831
16. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GSH, et al. Plos Genetics 2007 3 4 64 10.1371/journal.pgen.0030064 17465682 (Pubitemid 46683479)
17. Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Medina-Gomez G, Yetukuri L, Velagapudi V, Campbell M, Blount M, Jimenez-Linan M, Ros M, Oresic M, Vidal-Puig A, Disease Models & Mechanisms 2009 2 (11 12):582-592 10.1242/dmm.002295 22229125
18. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, et al. PLoS Genet 2007 3 4 64 10.1371/journal.pgen.0030064 17465682 (Pubitemid 46683479)
19. Molecular control of cell cycle progression in the pancreatic beta-cell. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocana A, Vasavada R, Stewart AF, Endocr Rev 2006 27 4 356 370 10.1210/er.2006-0004 16638909 (Pubitemid 43848303)
20. Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced beta-cell function in non-diabetic subjects. Weyrich P, Staiger H, Stancakova A, Schafer SA, Kirchhoff K, Ullrich S, Ranta F, Gallwitz B, Stefan N, Machicao F, et al. BMC Med Genet 2009 10 77 19682370
21. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Gradwohl G, Dierich A, LeMeur M, Guillemot F, Proc Natl Acad Sci USA 2000 97 4 1607 1611 10.1073/pnas.97.4.1607 10677506 (Pubitemid 30118489)
22. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, Berndt SI, Elliott AL, Jackson AU, Lamina C, et al. Nat Genet 2009 41 1 25 34 10.1038/ng.287 19079261
23. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferatoractivated receptor gamma. Sarruf DA, Iankova I, Abella A, Assou S, Miard S, Fajas L, Mol Cell Biol 2005 25 22 9985 9995 10.1128/MCB.25.22.9985- 9995.2005 16260612 (Pubitemid 41572745)
24. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPARgamma). Miana M, de Las Heras N, Rodriguez C, Sanz-Rosa D, Martin-Fernandez B, Mezzano S, Lahera V, Martinez-Gonzalez J, Cachofeiro V, J Physiol Pharmacol 2011 62 1 87 94 21451213
25. Peroxisome proliferator-activated receptorgamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Wang W, Liu F, Chen N, Mediators Inflamm 2007 2007 62641 18274641
26. The role of perforin and granzymes in diabetes. Thomas HE, Trapani JA, Kay TW, Cell Death Differ 2010 17 4 577 585 10.1038/cdd.2009.165 19927156
27. Primary hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity. Bonfleur ML, Vanzela EC, Ribeiro RA, de Gabriel Dorighello G, de Franca Carvalho CP, Collares-Buzato CB, Carneiro EM, Boschero AC, de Oliveira HC, Biochim Biophys Acta 2010 1801 2 183 190 10.1016/j.bbalip.2009.10.012 19913637
28. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. Joyce CW, Wagner EM, Basso F, Amar MJ, Freeman LA, Shamburek RD, Knapper CL, Syed J, Wu J, Vaisman BL, et al. J Biol Chem 2006 281 44 33053 33065 10.1074/jbc.M604526200 16928680 (Pubitemid 46036688)
29. Stimulus-induced Snitrosylation of Syntaxin 4 impacts insulin granule exocytosis. Wiseman DA, Kalwat MA, Thurmond DC, J Biol Chem 2011 286 18 16344 16354 10.1074/jbc.M110.214031 21393240
30. Inhibition of arsenic induced-rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-beta/Smad activation. Pan X, Dai Y, Li X, Niu N, Li W, Liu F, Zhao Y, Yu Z, Toxicol Appl Pharmacol 2011 254 3 323 31 10.1016/j.taap.2011.04.022 21605584
31. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Wijesekara N, Dai FF, Hardy AB, Giglou PR, Bhattacharjee A, Koshkin V, Chimienti F, Gaisano HY, Rutter GA, Wheeler MB, Diabetologia 2010 53 8 1656 1668 10.1007/s00125-010-1733-9 20424817
32. Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes - a meta-analysis. Xu K, Zha M, Wu X, Yu Z, Yu R, Xu X, Chen H, Yang T, Diabetes Res Clin Pract 2011 91 2 195 202 10.1016/j.diabres.2010.11.012 21131091
33. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bolstad BM, Irizarry RA, Astrand M, Speed TP, Bioinformatics 2003 19 2 185 193 10.1093/bioinformatics/19.2.185 12538238 (Pubitemid 36181903)
34. limmaGUI: a graphical user interface for linear modeling of microarray data. Wettenhall JM, Smyth GK, Bioinformatics 2004 20 18 3705 3706 10.1093/bioinformatics/bth449 15297296 (Pubitemid 40136823)
35. More powerful procedures for multiple significance testing. Hochberg Y, Benjamini Y, Stat Med 1990 9 7 811 818 10.1002/sim.4780090710 2218183 (Pubitemid 20343989)
36. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Al-Shahrour F, Diaz-Uriarte R, Dopazo J, Bioinformatics 2004 20 4 578 580 10.1093/bioinformatics/btg455 14990455 (Pubitemid 38344339)
37. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Al-Shahrour F, Minguez P, Tarraga J, Medina I, Alloza E, Montaner D, Dopazo J, Nucleic Acids Res 2007 35 Web Server 91 96
38. Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, Conesa A, Tarraga J, Pascual-Montano A, Nogales-Cadenas R, Santoyo J, et al. Nucleic Acids Res 2010 38 Web Server 210 213
39. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Benjamini Y, Hochberg Y, Journal of the Royal Statistical Society 1995 57 1 289 300
40. Controlling the false discovery rate in behavior genetics research. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, Behav Brain Res 2001 125 1-2 279 284 10.1016/S0166-4328(01)00297-2 11682119 (Pubitemid 33000466)